175 related articles for article (PubMed ID: 20098764)
1. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers.
Basanta M; Jarvis RM; Xu Y; Blackburn G; Tal-Singer R; Woodcock A; Singh D; Goodacre R; Thomas CL; Fowler SJ
Analyst; 2010 Feb; 135(2):315-20. PubMed ID: 20098764
[TBL] [Abstract][Full Text] [Related]
2. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
3. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
4. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
5. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
6. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
9. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath.
Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP
Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239
[TBL] [Abstract][Full Text] [Related]
11. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
[TBL] [Abstract][Full Text] [Related]
12. Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.
Allers M; Langejuergen J; Gaida A; Holz O; Schuchardt S; Hohlfeld JM; Zimmermann S
J Breath Res; 2016 Apr; 10(2):026004. PubMed ID: 27058460
[TBL] [Abstract][Full Text] [Related]
13. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study.
Basanta M; Ibrahim B; Dockry R; Douce D; Morris M; Singh D; Woodcock A; Fowler SJ
Respir Res; 2012 Aug; 13(1):72. PubMed ID: 22916684
[TBL] [Abstract][Full Text] [Related]
14. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
[TBL] [Abstract][Full Text] [Related]
15. Observation of nonanoic acid and aldehydes in exhaled breath of patients with lung cancer.
Callol-Sanchez L; Munoz-Lucas MA; Gomez-Martin O; Maldonado-Sanz JA; Civera-Tejuca C; Gutierrez-Ortega C; Rodriguez-Trigo G; Jareno-Esteban J
J Breath Res; 2017 Apr; 11(2):026004. PubMed ID: 28440225
[TBL] [Abstract][Full Text] [Related]
16. How long may a breath sample be stored for at -80 °C? A study of the stability of volatile organic compounds trapped onto a mixed Tenax:Carbograph trap adsorbent bed from exhaled breath.
Kang S; Paul Thomas CL
J Breath Res; 2016 Jun; 10(2):026011. PubMed ID: 27272219
[TBL] [Abstract][Full Text] [Related]
17. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
[TBL] [Abstract][Full Text] [Related]
18. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
19. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
[No Abstract] [Full Text] [Related]
20. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]